Kangmei Pharmaceutical Co., Ltd. (SHSE: 600518)
Health Care · Pharmaceuticals · CN
CN¥1.34
+0.75% today · -34.3% 1Y
Kangmei Pharmaceutical Co., Ltd. (SHSE: 600518) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.76B and employs 5,492 people.
Over the last twelve months the share price has lost 34.3%, trading between 1.16 and 2.16.
Tweenvest scores Kangmei Pharmaceutical Co., Ltd. across four factors: quality 60/100, value 25/100, growth 13/100. Its strongest factor is quality.
600518 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.76B
- Revenue (TTM)
- $730.97M
- P/E
- —
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- CN¥2.16
- 52-week low
- CN¥1.16
- Avg volume (3M)
- —
- Shares outstanding
- 13.83B
- Employees
- 5,492
- Next earnings
- —
About Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is based in Shenzhen, China.
- ISIN
- CNE0000017M1
- Founded
- 1997
- Listed since
- Mar 19, 2001
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Neuland Laboratories LimitedBSE: 524558 | $2.86B | Rs21,496.30 | -1.86% |
| MBX Biosciences, Inc.NasdaqGS: MBX | $2.82B | $53.25 | -8.99% |
| Rubicon Research LimitedNSEI: RUBICON | $2.80B | Rs1,630.90 | -2.71% |
| Harbin Pharmaceutical Group Co., Ltd.SHSE: 600664 | $2.78B | CN¥7.40 | -9.09% |
| Piramal Pharma LimitedNSEI: PPLPHARMA | $2.73B | Rs197.97 | -5.87% |
| Acutaas Chemicals LimitedNSEI: ACUTAAS | $2.72B | Rs3,196.50 | -2.32% |
| Joincare Pharmaceutical Group Industry Co.,Ltd.SHSE: 600380 | $2.70B | CN¥9.90 | -2.56% |
| Curaleaf Holdings, Inc.TSX: CURA | $2.64B | CA$13.50 | -5.00% |
Figures last refreshed Oct 4, 2026.